Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Posted On Friday, August 15, 2025
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, August 15, 2025
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies
Posted On Friday, August 15, 2025
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
Posted On Friday, August 15, 2025
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025
Posted On Thursday, August 14, 2025
Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH
Posted On Thursday, August 14, 2025
INVO Fertility Announces Second Quarter 2025 Financial Results
Posted On Thursday, August 14, 2025
COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update
Posted On Thursday, August 14, 2025
Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025
Posted On Thursday, August 14, 2025
BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025
Posted On Thursday, August 14, 2025
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
Posted On Thursday, August 14, 2025
Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Posted On Thursday, August 14, 2025
Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19
Posted On Thursday, August 14, 2025
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
Posted On Thursday, August 14, 2025
Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Posted On Thursday, August 14, 2025
Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
Posted On Thursday, August 14, 2025
Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights
Posted On Thursday, August 14, 2025
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
Posted On Thursday, August 14, 2025
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Posted On Thursday, August 14, 2025
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025
Posted On Thursday, August 14, 2025
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Posted On Thursday, August 14, 2025
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
Posted On Thursday, August 14, 2025
GT Biopharma Reports Second Quarter 2025 Financial Results
Posted On Thursday, August 14, 2025
Shuttle Pharma Provides Second Quarter 2025 Corporate Update
Posted On Thursday, August 14, 2025
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
Posted On Thursday, August 14, 2025

Print